Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: The role of fibroblast growth factor 23

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Biofactors

• Publication date

  2014-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/biof.1186PMID 25352227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis

  2014cited by this paper
• Functional heterogeneity of osteocytes in FGF23 production: the possible involvement of DMP1 as a direct negative regulator.

  2014cited by this paper
• Analysis of vitamin D metabolism gene expression in human bone: evidence for autocrine control of bone remodelling.

  2014cited by this paper
• PHEX Mimetic (SPR4-Peptide) Corrects and Improves HYP and Wild Type Mice Energy-Metabolism

  2014cited by this paper
• Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption–formation cycles?

  2014cited by this paper
• Vitamin D Represses Dentin Matrix Protein 1 in Cementoblasts and Osteocytes

  2014influential reference
• Dysregulated Gene Expression in the Primary Osteoblasts and Osteocytes Isolated from Hypophosphatemic Hyp Mice

  2014influential reference
• Hypophosphatemic osteomalacia and bone sclerosis caused by a novel homozygous mutation of the FAM20C gene in an elderly man with a mild variant of Raine syndrome.

  2014cited by this paper
• Functional analysis of mutant FAM20C in Raine syndrome with FGF23-related hypophosphatemia.

  2014cited by this paper
• Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia.

  2014cited by this paper
• Effects of Extracellular Phosphate on Gene Expression in Murine Osteoblasts

  2014cited by this paper
• FGF23 Affects the Lineage Fate Determination of Mesenchymal Stem Cells

  2013cited by this paper
• Extracellular phosphate modulates the effect of 1α,25-dihydroxy vitamin D3 (1,25D) on osteocyte like cells.

  2013cited by this paper
• Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X‐linked hypophosphatemia

  2013cited by this paper
• Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism.

  2013cited by this paper
• FGF23 production by osteocytes

  2013cited by this paper
• Early chronic kidney disease-mineral bone disorder stimulates vascular calcification

  2013cited by this paper
• Fibroblast Growth Factor 23 and Klotho Are Present in the Growth Plate

  2013cited by this paper
• An integrated understanding of the physiological response to elevated extracellular phosphate

  2013cited by this paper
• Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community.

  2013cited by this paper
• Retinol deprivation partially rescues the skeletal mineralization defects of Phex-deficient Hyp mice.

  2013cited by this paper
• Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium

  2013influential reference
• Increased Col10a1 expression is not causative for the phenotype of Phex-deficient Hyp mice.

  2013cited by this paper
• Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia.

  2013cited by this paper
• Exome sequencing reveals FAM20c mutations associated with fibroblast growth factor 23–related hypophosphatemia, dental anomalies, and ectopic calcification

  2013cited by this paper
• Osteocyte-Driven Bone Remodeling

  2013cited by this paper
• Nuclear localization of DMP1 proteins suggests a role in intracellular signaling.

  2012cited by this paper
• Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.

  2012cited by this paper
• Repression of osteocyte Wnt/β‐catenin signaling is an early event in the progression of renal osteodystrophy

  2012cited by this paper
• Secreted Kinase Phosphorylates Extracellular Proteins That Regulate Biomineralization

  2012influential reference
• Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading.

  2012cited by this paper
• Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease.

  2012cited by this paper
• Targeted deletion of Sost distal enhancer increases bone formation and bone mass

  2012cited by this paper
• FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality.

  2012cited by this paper
• New insights into NPP1 function: lessons from clinical and animal studies.

  2012cited by this paper
• DNA methylation contributes to the regulation of sclerostin expression in human osteocytes

  2012cited by this paper
• Phosphate/Pyrophosphate and MV-related Proteins in Mineralisation: Discoveries from Mouse Models

  2012cited by this paper
• Inactivation of a Novel FGF23 Regulator, FAM20C, Leads to Hypophosphatemic Rickets in Mice

  2012influential reference
• Altered Bone Development and an Increase in FGF-23 Expression in Enpp1−/− Mice

  2012cited by this paper
• Calcium deficiency reduces circulating levels of FGF23.

  2012cited by this paper
• An overview of the regulation of bone remodelling at the cellular level.

  2012cited by this paper
• The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis

  2012cited by this paper
• Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling

  2011influential reference
• Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo.

  2011cited by this paper
• FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF‐23 signaling and regulating FGF‐23 expression in bone

  2011cited by this paper
• Fibroblast Growth Factor 23 (FGF23) and Alpha-Klotho Stimulate Osteoblastic MC3T3.E1 Cell Proliferation and Inhibit Mineralization

  2011cited by this paper
• The Appearance and Modulation of Osteocyte Marker Expression during Calcification of Vascular Smooth Muscle Cells

  2011cited by this paper
• Vitamin D metabolism within bone cells: effects on bone structure and strength.

  2011cited by this paper
• The expanding family of hypophosphatemic syndromes

  2011cited by this paper
• FGF‐23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH

  2011cited by this paper
• Phosphate sensing.

  2011cited by this paper
• Sclerostin is a locally acting regulator of late‐osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE‐ASARM‐dependent mechanism

  2011cited by this paper
• Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo.

  2011cited by this paper
• Long‐term cadmium exposure and the association with bone mineral density and fractures in a population‐based study among women

  2011cited by this paper
• Bone mineralization and regulation of phosphate homeostasis

  2011cited by this paper
• PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.

  2010cited by this paper
• The emergence of phosphate as a specific signaling molecule in bone and other cell types in mammals

  2010cited by this paper
• Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption.

  2010cited by this paper
• Cellular and Molecular Mechanisms of Bone Remodeling*

  2010cited by this paper
• Cellular mechanisms of bone remodeling

  2010cited by this paper
• Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets.

  2010cited by this paper
• Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene.

  2010cited by this paper
• Novel regulators of Fgf23 expression and mineralization in Hyp bone.

  2009cited by this paper
• Sclerostin Mediates Bone Response to Mechanical Unloading Through Antagonizing Wnt/β‐Catenin Signaling

  2009cited by this paper
• FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player?

  2009cited by this paper
• Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation

  2009cited by this paper
• Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase.

  2009cited by this paper
• In vivo genetic evidence for klotho‐dependent, fibroblast growth factor 23 (Fgf23) ‐mediated regulation of systemic phosphate homeostasis

  2009cited by this paper
• Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model

  2009cited by this paper
• Parathyroid hormone signaling in bone and kidney

  2009cited by this paper
• Bone formation regulates circulating concentrations of fibroblast growth factor 23.

  2009cited by this paper
• Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype.

  2009cited by this paper
• Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia.

  2008cited by this paper
• Overexpression of Fibroblast Growth Factor 23 Suppresses Osteoblast Differentiation and Matrix Mineralization In Vitro

  2008cited by this paper
• Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone

  2008cited by this paper
• Histological and elemental analyses of impaired bone mineralization in klotho‐deficient mice

  2008cited by this paper
• Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans

  2007cited by this paper
• Pyrophosphate Inhibits Mineralization of Osteoblast Cultures by Binding to Mineral, Up-regulating Osteopontin, and Inhibiting Alkaline Phosphatase Activity*

  2007cited by this paper
• 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism.

  2007cited by this paper
• Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3.

  2007cited by this paper
• The parathyroid is a target organ for FGF23 in rats.

  2007cited by this paper
• How fibroblast growth factor 23 works.

  2007cited by this paper
• Low bone mineral density and fracture burden in postmenopausal women

  2007cited by this paper
• Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism.

  2007cited by this paper
• Mineralized tissue cells are a principal source of FGF23.

  2007cited by this paper
• Osteocytes as Dynamic Multifunctional Cells

  2007cited by this paper
• Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells.

  2007cited by this paper
• Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.

  2007cited by this paper
• Mutations in FAM20C are associated with lethal osteosclerotic bone dysplasia (Raine syndrome), highlighting a crucial molecule in bone development.

  2007cited by this paper
• Pathogenic role of Fgf23 in Hyp mice.

  2006cited by this paper
• Klotho converts canonical FGF receptor into a specific receptor for FGF23

  2006cited by this paper
• Regulation of C‐Terminal and Intact FGF‐23 by Dietary Phosphate in Men and Women

  2006cited by this paper
• Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

  2006cited by this paper
• Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase/phosphodiesterase family focusing on NPP1 in calcification

  2006cited by this paper
• Regulation of Fibroblast Growth Factor-23 Signaling by Klotho*

  2006cited by this paper
• Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism

  2006cited by this paper
• Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.

  2006cited by this paper
• Parathyroid hormone: past and present.

  2005cited by this paper
• DMP1 Depletion Decreases Bone Mineralization In Vivo: An FTIR Imaging Analysis

  2005cited by this paper
• Dlx5 Specifically Regulates Runx2 Type II Expression by Binding to Homeodomain-response Elements in the Runx2 Distal Promoter*

  2005cited by this paper

• IL-34 as a Novel Mediator Linking Vitamin D Deficiency with Osteoporosis and Knee Osteoarthritis

  2025cites this paper
• Marked increase in bone mineral density with oral phosphate and calcitriol in tumour-induced osteomalacia

  2023cites this paper
• Prenatal and Neonatal Bone Health: Updated Review on Early Identification of Newborns at High Risk for Osteopenia

  2023cites this paper
• A design logic for sequential segmentation across organisms

  2023cites this paper
• Effect of Oxidative Stress-Induced Apoptosis on Active FGF23 Levels in MLO-Y4 Cells: The Protective Role of 17-β-Estradiol

  2022cites this paper
• Axial mechanical loading to ex vivo mouse long bone regulates endochondral ossification and endosteal mineralization through activation of the BMP-Smad pathway during postnatal growth

  2021influential citation
• Hypertrophic chondrocytes serve as a reservoir for marrow-associated skeletal stem and progenitor cells, osteoblasts, and adipocytes during skeletal development

  2021cites this paper
• Therapeutic and mechanistic approaches of Tridax procumbens flavonoids for the treatment of osteoporosis.

  2020cites this paper
• Current advances in regulation of bone homeostasis

  2020cites this paper
• Long-term bone mineral density changes after surgical cure of patients with tumor-induced osteomalacia

  2020cites this paper
• Effects of parathyroidectomy on the biology of bone tissue in patients with chronic kidney disease and secondary hyperparathyroidism.

  2019cites this paper
• Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia.

  2019cites this paper
• Pathogenesis of Osteoporosis

  2019cites this paper
• Assessment of the Concentration of Bone Metabolism Markers: Sclerostin and FGF-23 in Children with Idiopathic Nephrotic Syndrome Treated with Glucocorticosteroids

  2019cites this paper
• Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt

  2019cites this paper
• Osteoclast-derived miR-23a-5p-containing exosomes inhibit osteogenic differentiation by regulating Runx2.

  2019cites this paper
• Phosphorus Dynamics in Ruminants-An Overview

  2019cites this paper
• Influence of concentration and preparation of platelet rich fibrin on human bone marrow mononuclear cells (in vitro)

  2018cites this paper
• Role of αKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters

  2018cites this paper
• Osteocytes Osteozyten

  2018cites this paper
• Bone Turnover Status: Classification Model and Clinical Implications

  2018cites this paper
• Involvement of bone in systemic endocrine regulation.

  2018cites this paper
• Effects of Nutritional Deficiency of Boron on the Bones of the Appendicular Skeleton of Mice

  2018cites this paper
• Targeted Disruption of NF1 in Osteocytes Increases FGF23 and Osteoid With Osteomalacia‐like Bone Phenotype

  2017cites this paper
• Fibroblast Growth Factor 23 Regulation by Systemic and Local Osteoblast-Synthesized 1,25-Dihydroxyvitamin D.

  2017cites this paper
• BRACHYURY directs histone acetylation to target loci during mesoderm development

  2017cites this paper
• A study on the sternum growth and mineralization kinetic of meat duck from 35 to 63 days of age

  2017cites this paper
• Molecular and Biochemical Aspects of Hypophosphatemic Rickets; an Updated Review

  2017cites this paper
• Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement.

  2016cites this paper
• Mechanisms of soft-tissue mineralization induced by the inhibition of the MEK/ERK pathway or the inhibition of fibroblast growth factor receptors

  2016cites this paper
• Molecular mechanism for cyclic generation of somites: Lessons from mice and zebrafish

  2016cites this paper
• Fgf3‐Fgf4‐cis: A new mouse line for studying Fgf functions during mouse development

  2016cites this paper
• Revisiting the involvement of signaling gradients in somitogenesis

  2016cites this paper
• Transplantation of bone marrow-derived mesenchymal stem cells rescues partially rachitic phenotypes induced by 1,25-Dihydroxyvitamin D deficiency in mice.

  2016cites this paper
• The osteoimmunology of alveolar bone loss

  2016cites this paper
• Sclerostin, TNF‐alpha and Interleukin‐18 Correlate and are Together with Klotho Related to Other Growth Factors and Cytokines in Haemodialysis Patients

  2016cites this paper
• Seven novel and six de novo PHEX gene mutations in patients with hypophosphatemic rickets

  2016cites this paper
• Editorial: is it time for an evolutionarily based human endocrinology?

  2015cites this paper
• The Fibroblast Growth Factor signaling pathway

  2015cites this paper
• Region‐specific regulation of posterior axial elongation during vertebrate embryogenesis

  2014cites this paper